(Source: PRNewswire-FirstCall)
MADISON, N.J., June 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated , the world's leading provider of diagnostic testing, information and services, announced today the determination of the pricing for its previously announced cash tender offer to purchase up to $200 million total aggregate principal amount (the "Tender Cap") of its 5.125% Senior Notes due 2010 and 7.50% Senior Notes due 2011 (collectively, the "Notes"). The terms and conditions of the tender offer are described in the Offer to Purchase, dated May 19, 2009 and related Letter of Transmittal.
Quest Diagnostics will pay holders who validly tendered and did not validly withdraw their Notes at or prior to 5:00 p.m., New York City time, on June 2, 2009 (the "Early Tender Date") the Total Tender Offer Consideration of $1,021.49 for each $1,000 principal amount of its 5.125% Senior Notes due 2010 accepted for purchase and $1,050.44 for each $1,000 principal amount of its 7.50% Senior Notes due 2011 accepted for purchase, plus, in each case, accrued and unpaid interest up to, but not including, the settlement date.
The Total Tender Offer Consideration, which includes an Early Tender Premium of $30 per $1,000 principal amount of the Notes tendered, has been determined for each series of Notes by reference to the applicable fixed spread over the applicable Reference Yield based on the bid-side price of the applicable Reference Treasury Security, as calculated by Banc of America Securities LLC, the Lead Dealer Manager, at 2:00 p.m., New York City time, on June 12, 2009. The formula for determining the Total Tender Offer Consideration is set forth in Schedule A of the Offer to Purchase. The Total Tender Offer Consideration and the applicable Reference Yields are detailed in the table below.
